It’s time to take control of Medicaid before it takes control of us. Unless we act — and there is little evidence that we will — Medicaid increasingly becomes another mechanism by which government skews spending toward the old and away from the young. In the raging debate over the Affordable Care Act (Obamacare), this is a subject that …

  Have money, can’t buy. That’s the dilemma facing China’s drugmakers as they look to acquire overseas assets to sate the country’s growing healthcare needs. Snapping up vitamin producers and the like hasn’t proved a problem, but snaring actual pharmaceuticals manufacturers is a different matter, and will be put to the test as Germany’s Stada Arzneimittel AG hits the brakes …

  It says something about the state of European politics that the Dutch election results are widely seen as cause for celebration. Geert Wilders — a far-right populist who makes Donald Trump look like a cautious centrist — did worse than expected. But he was by no means crushed, and the anger Wilders and his ilk are channeling is still …